Frequent Iss of tumor suppressor FUS1 protein expression in benign and malignant human mesenchymal tumors

被引：0
|
作者：
Li, Guidong
Kawashima, Hiroyuki
Ji, Lin
Ogose, Akira
Ariizumi, Takashi
Hotta, Tetsuo
Endo, Naoto
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
615
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study
    Hosny, Ghada
    Ahmed, Omar A.
    Ahmed, Rania Makboul
    Fadel, Sabah Ahmed
    [J]. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (01) : 66 - 74
  • [32] NELL-1 expression in benign and malignant bone tumors
    Shen, Jia
    LaChaud, Greg
    Khadarian, Kevork
    Shrestha, Swati
    Zhang, Xinli
    Soo, Chia
    Ting, Kang
    Dry, Sarah M.
    James, Aaron W.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (02) : 368 - 374
  • [33] Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors
    Svoboda, Martin
    Thalhammer, Theresia
    Aust, Sylvia
    Arrich, Ferdi
    Assadian, Ojan
    Toma, Cyril D.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (07) : 572 - 581
  • [34] Expression of human telomerase subunits in ovarian malignant borderline and benign tumors
    Kyo, S
    Kanaya, T
    Takakura, M
    Tanaka, M
    Yamashita, A
    Inoue, H
    Inoue, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (06) : 804 - 809
  • [35] Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas/Adenosquamous Carcinomas of the Uterine Cervix
    Katagiri, Atsuko
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Rahman, Munmun
    Katagiri, Hiroshi
    Ishikawa, Masako
    Ishibashi, Tomoka
    Iida, Kouji
    Otsuki, Yoshiro
    Nakayama, Satoru
    Miyazaki, Kohji
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (02) : 208 - 212
  • [36] Frequent alteration in expression and structure of a candidate tumor suppressor, RIZ, in human leukemia.
    Sasaki, O
    Meguro, K
    Shibahara, S
    Kameoka, J
    Sasaki, T
    [J]. BLOOD, 2000, 96 (11) : 704A - 704A
  • [37] The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner
    Meng, Jieru
    Majidi, Mourad
    Fang, Bingliang
    Ji, Lin
    Bekele, B. Nebiyou
    Minna, John D.
    Roth, Jack A.
    [J]. PLOS ONE, 2013, 8 (10):
  • [38] Tumor Suppressor Candidate 2 (TUSC2, FUS-1) and Human Cancers
    Rimkus, Tadas
    Sirkisoon, Sherona
    Harrison, Alexandra
    Lo, Hui-Wen
    [J]. DISCOVERY MEDICINE, 2017, 23 (128) : 325 - 330
  • [39] Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors
    Shimakage, Misuzu
    Kodama, Ken
    Kawahara, Kunimitsu
    Kim, Chul Jang
    Ikeda, Yoshihiko
    Yutsudo, Masuo
    Inoue, Hirokazu
    [J]. ONCOLOGY REPORTS, 2009, 21 (06) : 1367 - 1372
  • [40] ABERRANT EXPRESSION OF THE TUMOR SUPPRESSOR GENE P53 IS VERY FREQUENT IN WILMS-TUMORS
    LEMOINE, NR
    HUGHES, CM
    COWELL, JK
    [J]. JOURNAL OF PATHOLOGY, 1992, 168 (02): : 237 - 242
12345